Mahal Jeetinder Singh Insider Trades

Insider Trading History

Track insider trading activity for Mahal Jeetinder Singh. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Jasper Therapeutics
Jasper Therapeutics JSPR
CEO And President
Holding Value $241k 500,000 shares
Last Trade
Feb 06, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$675k 500,000 shares
$1.35
$0.48
Jasper Therapeutics- Warrants (24/09/2026)
Jasper Therapeutics- Warrants (24/09/2026) JSPRW
CEO And President
Holding Value $7.3k 500,000 shares
Last Trade
Feb 06, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.1k 500,000 shares
$0.02
$0.01
Jasper Therapeutics
Jasper Therapeutics JSPR
Chief Operating Officer
Holding Value $43.3k 90,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$166k 90,000 shares
$1.84
$0.48
Jasper Therapeutics- Warrants (24/09/2026)
Jasper Therapeutics- Warrants (24/09/2026) JSPRW
Chief Operating Officer
Holding Value $1.31k 90,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.14k 90,000 shares
$0.07
$0.01
Jasper Therapeutics- Warrants (24/09/2026)
Jasper Therapeutics- Warrants (24/09/2026) JSPRW
Chief Operating Officer
Holding Value $1.31k 90,000 shares
Last Trade
Jun 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.56k 90,000 shares
$0.10
$0.01
Jasper Therapeutics
Jasper Therapeutics JSPR
Chief Operating Officer
Holding Value $43.3k 90,000 shares
Last Trade
Jun 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$540k 90,000 shares
$6.00
$0.48
Jasper Therapeutics
Jasper Therapeutics JSPR
Chief Operating Officer
Holding Value $24.1k 50,000 shares
Last Trade
Feb 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$275k 50,000 shares
$5.49
$0.48
Jasper Therapeutics- Warrants (24/09/2026)
Jasper Therapeutics- Warrants (24/09/2026) JSPRW
Chief Operating Officer
Holding Value $730 50,000 shares
Last Trade
Feb 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.92k 50,000 shares
$0.16
$0.01
Jasper Therapeutics- Warrants (24/09/2026)
Jasper Therapeutics- Warrants (24/09/2026) JSPRW
Chief Operating Officer
Holding Value $378 25,909 shares
Last Trade
Dec 12, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$200 900 shares
$0.22
$0.01
Jasper Therapeutics- Warrants (24/09/2026)
Jasper Therapeutics- Warrants (24/09/2026) JSPRW
Chief Operating Officer
Holding Value $365 25,009 shares
Last Trade
Dec 12, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$200 900 shares
$0.22
$0.01
Jasper Therapeutics
Jasper Therapeutics JSPR
Chief Operating Officer
Holding Value $12k 25,009 shares
Last Trade
Dec 12, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$19.9k 900 shares
$22.11
$0.48
Jasper Therapeutics
Jasper Therapeutics JSPR
Chief Operating Officer
Holding Value $12.5k 25,909 shares
Last Trade
Dec 12, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$18.4k 900 shares
$20.47
$0.48
Jasper Therapeutics- Warrants (24/09/2026)
Jasper Therapeutics- Warrants (24/09/2026) JSPRW
Chief Operating Officer
Holding Value $365 25,009 shares
Last Trade
Sep 12, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$194 900 shares
$0.22
$0.01
Jasper Therapeutics- Warrants (24/09/2026)
Jasper Therapeutics- Warrants (24/09/2026) JSPRW
Chief Operating Officer
Holding Value $378 25,909 shares
Last Trade
Sep 12, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$387 1,800 shares
$0.22
$0.01
Jasper Therapeutics
Jasper Therapeutics JSPR
Chief Operating Officer
Holding Value $12k 25,009 shares
Last Trade
Sep 12, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$19.1k 900 shares
$21.23
$0.48
Jasper Therapeutics
Jasper Therapeutics JSPR
Chief Operating Officer
Holding Value $12.5k 25,909 shares
Last Trade
Sep 12, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$19.3k 900 shares
$21.47
$0.48
Jasper Therapeutics
Jasper Therapeutics JSPR
Chief Operating Officer
Holding Value $12k 25,009 shares
Last Trade
Jun 12, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$21.7k 900 shares
$24.16
$0.48
Jasper Therapeutics- Warrants (24/09/2026)
Jasper Therapeutics- Warrants (24/09/2026) JSPRW
Chief Operating Officer
Holding Value $365 25,009 shares
Last Trade
Jun 12, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$189 900 shares
$0.21
$0.01
Jasper Therapeutics
Jasper Therapeutics JSPR
Chief Operating Officer
Holding Value $12.5k 25,909 shares
Last Trade
Jun 12, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$21.6k 900 shares
$24.00
$0.48
Jasper Therapeutics- Warrants (24/09/2026)
Jasper Therapeutics- Warrants (24/09/2026) JSPRW
Chief Operating Officer
Holding Value $378 25,909 shares
Last Trade
Jun 12, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$378 1,800 shares
$0.21
$0.01

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up